Journal of Advanced Biotechnology and Experimental Therapeutics
✅ After receiving, the manuscript will be primarily checked by the Editor-in-Chief. If the manuscript is not well formatted, it will be sent back to the corresponding author. If the content is not satisfactory or does not match the scopes of JABET, the manuscript will be sent back as rejected instantly. Upon passing the preliminary screening, the manuscript will be sent to at least two expert peer reviewers.
✅ A reviewer invitation from JABET is sent out by e-mail. Only title and abstract of the manuscript are included in the invitation e-mail. After accepting the invitation, the reviewer gets full access to the entire manuscript. Information about the reviewers are kept confidential (closed).
✅ After the completion of the peer-review process, the revised manuscript is sent to the section /associate editor for critical checking and seeking the primary comments whether the manuscript can be accepted. A decision on a manuscript is finally made by the Editor-in-Chief considering the comments of the expert reviewers and the section editor.
✅ The decision may be any one of the following:
👉 Accept (with or without editorial revision)
👉 Suggest the authors for more revision
👉 Reject with the possibility of resubmission: The authors are informed that further work might justify a resubmit.
👉 Reject, typically on grounds of specialist interest, lack of novelty, insufficient conceptual advance or major technical and/or interpretational problem.
✅ On an average, the peer-review process is expected to be finished within 4 weeks. The decision by the Editor-in-Chief is given within 4-5 weeks.